The semaglutide group lost an average of 5.2 kg, compared to 1.9 kg in the placebo group [Citation19]
But the cellular response is weaker, and the appetite suppression and metabolic effects you were counting on simply do not materialize the way they should
Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication
However, this is an average from studies, and your timeline will depend on a combination of factors, including your starting weight, dosage, and commitment to lifestyle changes
As weve seen in our own program over the last year, the benefits of these medications far outweigh the risks which is why we understand and support patients who feel like they dont want to quit the medications cold turkey. Keep in mind that the FDA has approved the medications for indefinite use
2025 Oct;85(4):e23000